Inadequate adherence to antiretroviral treatment and prevention in hospital and community sites in Burkina Faso and Mali: a study by the ATARAO group

被引:11
作者
Aboubacrine, S. Ag
Niamba, P.
Boileau, C.
Zunzunegui, M. V.
Machouf, N.
Nguyen, V. K.
Rashed, S.
机构
[1] Hop Natl Point G, Serv Med Interne, Bamako, Mali
[2] Univ Ouagadougou, Unite Format & Rech Sci Sante, Ouagadougou, Burkina Faso
[3] McGill Univ, Inst Hlth & Social Policy, Montreal, PQ, Canada
[4] Univ Montreal, Dept Med Social & Prevent, Montreal, PQ H3C 3J7, Canada
[5] Clin Med Actuel, Montreal, PQ, Canada
[6] Univ Montreal, Unite Sante Int, Montreal, PQ H3C 3J7, Canada
关键词
adherence; antiretroviral therapy; sub-Saharan Africa; serostatus disclosure; condom use;
D O I
10.1258/095646207782212243
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our objective was to determine the prevalence and identify the factors that influence antiretroviral therapy (ART) adherence among patients in Bamako and Ouagadougou. A cross-sectional study was conducted among 94 men and 176 women receiving ART Data were collected through questionnaires and chart reviews. Logistic regressions were performed to isolate determinants of adherence. Overall, 58% of the patients were adherent, but there were differences in the levels of adherence according to country and treatment site. Sociodemographic factors were not associated with adherence. However, social characteristics such as having children, in Ouagadougou, or being a housewife and not planning to have a child in the next year, in Bamako were associated with adherence. Time on ART was negatively associated with adherence in both countries with decline occurring later in Bamako. Levels of adherence are inadequate particularly among more experienced patients. Further adherence research and monitoring using longitudinal designs are warranted to assess the extent to which adherence is declining with time on treatment.
引用
收藏
页码:741 / 747
页数:7
相关论文
共 42 条
[1]  
AKAM AWC, 2004, 15 INT AIDS C
[2]   Non-adherence to highly active antiretroviral therapy predicts progression to AIDS [J].
Bangsberg, DR ;
Perry, S ;
Charlebois, ED ;
Clark, RA ;
Roberston, M ;
Zolopa, AR ;
Moss, A .
AIDS, 2001, 15 (09) :1181-1183
[3]  
Bekker LG, 2006, SAMJ S AFR MED J, V96, P315
[4]   A study on antiretroviral treatment compliance in Casablanca (Morocco) [J].
Benjaber, K ;
Rey, JL ;
Himmich, H .
MEDECINE ET MALADIES INFECTIEUSES, 2005, 35 (7-8) :390-395
[5]   Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage [J].
Boerma, JT ;
Stanecki, KA ;
Newell, ML ;
Luo, C ;
Beusenberg, M ;
Garnett, GP ;
Little, K ;
Calleja, JG ;
Crowley, S ;
Kim, JY ;
Zaniewski, E ;
Walker, N ;
Stover, J ;
Ghys, PD .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2006, 84 (02) :145-150
[6]   Nonadherence among HIV-Infected injecting drug users: The impact of social instability [J].
Bouhnik, AD ;
Chesney, M ;
Carrieri, P ;
Gallais, H ;
Moreau, J ;
Moatti, JP ;
Obadia, Y ;
Spire, B .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S149-S153
[7]  
BROWN S, 2004, 15 INT AIDS C
[8]   Adherence to HIV antiretroviral therapy in HIV plus Ugandan patients purchasing therapy [J].
Byakika-Tusiime, J ;
Oyugi, JH ;
Tumwikirize, WA ;
Katabira, ET ;
Mugyenyi, PN ;
Bangsberg, DR .
INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (01) :38-41
[9]   Failure to maintain adherence to HAART in a cohort of french HIV-positive injecting drug users [J].
Carrieri, MP ;
Chesney, MA ;
Spire, B ;
Loundou, A ;
Sobel, A ;
Lepeu, G ;
Moatti, JP .
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2003, 10 (01) :1-14
[10]  
DARDER M, 2004, 15 INT AIDS C